Skip to content

Clinical trials

Phase 2 Dwarfism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism Phase: Phase 2 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20141
20151
20161
20171
20181
20191
20204
20211
20222
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting6
Recruiting2
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical6
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
QED Therapeutics, a BridgeBio company3
Changchun GeneScience Pharmaceutical Co., Ltd.2
Andrew Dauber1
Ascendis Pharma A/S1
Nemours Children's Clinic1
Pfizer1
Roopa Kanakatti Shankar, MBBS, MS1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism22
Achondroplasia10
Bone Diseases10
Musculoskeletal Diseases8
Osteochondrodysplasias5
Bone Diseases, Developmental4
Genetic Diseases, Inborn4
Mucopolysaccharidosis IV4
Growth Disorders3
Turner Syndrome3

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.